| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
L-type calcium channel blocker that can inhibit calcium-mediated signaling in neurons, including those pathways associated with OR1Q1. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inactivates Gi/o type G proteins, altering GPCR signaling and can disrupt OR1Q1-mediated pathways. | ||||||
ODQ | 41443-28-1 | sc-200325 sc-200325A | 10 mg 50 mg | $78.00 $222.00 | 13 | |
Inhibits soluble guanylyl cyclase, potentially affecting cyclic GMP levels and can disrupt the signaling processes involving OR1Q1. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Protein kinase C inhibitor that can affect downstream signaling of GPCRs, including OR1Q1. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A sc-200402B sc-200402C | 50 mg 500 mg 5 g 10 g | $69.00 $364.00 $2500.00 $4100.00 | 11 | |
Dopamine antagonist that can modulate dopaminergic signaling and can indirectly affect OR1Q1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, potentially affecting the phosphorylation state of proteins in pathways involving OR1Q1. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Inhibits certain chloride channels, which can modulate cellular excitability and signaling pathways related to OR1Q1. | ||||||